Koninklijke Philips Operating Expenses 2010-2024 | PHG

Koninklijke Philips operating expenses for the twelve months ending September 30, 2024 were $17.623B, a 7.8% decline year-over-year.

  • Koninklijke Philips annual operating expenses for 2023 were $19.789B, a 2.96% decline from 2022.
  • Koninklijke Philips annual operating expenses for 2022 were $20.392B, a 3.82% increase from 2021.
  • Koninklijke Philips annual operating expenses for 2021 were $19.643B, a 4.43% decline from 2020.

Koninklijke Philips Operating Expenses 2010-2024 | PHG

  • Koninklijke Philips annual operating expenses for 2023 were $19.789B, a 2.96% decline from 2022.
  • Koninklijke Philips annual operating expenses for 2022 were $20.392B, a 3.82% increase from 2021.
  • Koninklijke Philips annual operating expenses for 2021 were $19.643B, a 4.43% decline from 2020.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$201B
Stryker (SYK)$148.7B
Boston Scientific (BSX)$128.2B
Medtronic (MDT)$112.3B
EssilorLuxottica (ESLOY)$110.5B
Haleon (HLN)$42.5B
Lonza Group Ag (LZAGY)$41.6B
GE HealthCare Technologies (GEHC)$37.4B
ResMed (RMD)$34.5B
Terumo (TRUMY)$29.1B
Zimmer Biomet Holdings (ZBH)$22.4B
Insulet (PODD)$18.2B
Baxter (BAX)$16.3B
Smith & Nephew SNATS (SNN)$10.9B
BellRing Brands (BRBR)$9.3B
Bio-Rad Laboratories (BIO)$9B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$5.3B
TG Therapeutics (TGTX)$4.6B
Haemonetics (HAE)$4.5B
ICU Medical (ICUI)$4.1B
Prestige Consumer Healthcare (PBH)$4.1B
Perrigo (PRGO)$3.7B
Envista Holdings (NVST)$3.5B
Neogen (NEOG)$3.2B
Agios Pharmaceuticals (AGIO)$3.1B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.9B
QuidelOrtho (QDEL)$2.4B
LeMaitre Vascular (LMAT)$2.3B